Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study to uncover hidden link between blood mutations and immune disorders

NCT ID NCT05969821

First seen Mar 30, 2026 · Last updated Jun 17, 2026 · Updated 11 times

Summary

This study will follow 5,000 adults with immune system problems to see if certain blood cell mutations (called clonal hematopoiesis) are linked to their condition. Researchers will track new cases of immune-related diseases over time. No treatments or drugs are tested—this is purely an observation study to gather information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP-HP, Service de médecine interne, Hôpital Saint Antoine

    Paris, 75012, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

autoimmune disease autoinflammatory syndrome chronic myelomonocytic leukemia clonal hematopoiesis clonal hematopoiesis of indeterminate potential hematologic disorder immune system disorder Inflammation inflammatory disease juvenile myelomonocytic leukemia leukemia lymphoma lymphoproliferative syndrome monoclonal gammopathy of uncertain significance myelodysplastic syndrome Myelodysplastic Syndromes myelodysplastic/myeloproliferative disease myelodysplastic/myeloproliferative neoplasm Myeloproliferative Disorders myeloproliferative neoplasm VEXAS syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.